Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$143.31 - $247.0 $2.01 Million - $3.46 Million
14,000 Added 83.33%
30,800 $7.48 Million
Q1 2024

May 14, 2024

SELL
$146.51 - $198.2 $3.27 Million - $4.42 Million
-22,300 Reduced 57.03%
16,800 $2.51 Million
Q4 2023

Feb 13, 2024

BUY
$151.41 - $196.57 $151,410 - $196,570
1,000 Added 2.62%
39,100 $7.48 Million
Q2 2023

Aug 11, 2023

BUY
$185.01 - $212.05 $1.41 Million - $1.61 Million
7,600 Added 24.92%
38,100 $7.24 Million
Q1 2023

May 12, 2023

SELL
$182.66 - $235.53 $3.25 Million - $4.19 Million
-17,800 Reduced 36.85%
30,500 $6.11 Million
Q4 2022

Feb 10, 2023

BUY
$185.53 - $241.31 $74,212 - $96,524
400 Added 0.84%
48,300 $11.5 Million
Q3 2022

Nov 14, 2022

BUY
$138.54 - $232.0 $3.46 Million - $5.8 Million
25,000 Added 109.17%
47,900 $9.59 Million
Q1 2022

May 13, 2022

SELL
$127.18 - $173.91 $432,412 - $591,294
-3,400 Reduced 12.93%
22,900 $3.74 Million
Q4 2021

Feb 11, 2022

BUY
$159.56 - $209.29 $4.2 Million - $5.5 Million
26,300 New
26,300 $4.46 Million
Q3 2021

Nov 12, 2021

SELL
$169.75 - $207.73 $4.24 Million - $5.19 Million
-25,000 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$128.63 - $176.89 $9.07 Million - $12.5 Million
-70,500 Reduced 73.82%
25,000 $4.24 Million
Q4 2020

Feb 12, 2021

BUY
$122.97 - $147.0 $24,594 - $29,400
200 Added 0.21%
95,500 $12.4 Million
Q2 2020

Aug 14, 2020

SELL
$104.21 - $156.44 $3.75 Million - $5.63 Million
-36,000 Reduced 27.42%
95,300 $14.1 Million
Q1 2020

May 14, 2020

BUY
$93.12 - $133.99 $1.8 Million - $2.59 Million
19,300 Added 17.23%
131,300 $14.3 Million
Q4 2019

Feb 13, 2020

BUY
$74.51 - $124.23 $1.27 Million - $2.12 Million
17,100 Added 18.02%
112,000 $12.9 Million
Q3 2019

Nov 08, 2019

BUY
$70.9 - $87.82 $5.81 Million - $7.19 Million
81,900 Added 630.0%
94,900 $7.63 Million
Q2 2019

Aug 14, 2019

BUY
$65.86 - $92.79 $856,180 - $1.21 Million
13,000 New
13,000 $943,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.